Generated August 24, 2026 at 8:31 PM ET
· Covers August 24 trading day
· 10 of 141 ready 8-Ks selected
· AI-assisted overview
{"overview": "On August 24, 2026, several companies disclosed significant regulatory and legal actions. Grand Canyon Education placed its CFO on paid leave amid a government probe, while Northann received a NYSE American delisting notice and moved to OTC trading. Expion360 raised $9M and acquired Louisiana oil & gas assets, and Martin Marietta closed its $13.5B Lhoist North America acquisition. REGENXBIO received an FDA clinical hold on RGX-121, and Hub Group faces a Nasdaq deficiency notice for delayed filings. Kimbell Royalty closed a $221.2M dropdown, Nutex Health reported a data breach, Sable Offshore was cleared to continue operations with a penalty, and Cytek Biosciences received a jury verdict with damages on one patent claim."}</think>{"overview": "On August 24, 2026, several filings disclosed significant regulatory, transactional, and legal developments. Grand Canyon Education placed its CFO on paid leave amid a government probe, while Northann received a delisting notice from NYSE American and moved to OTC trading. Expion360 raised $9M in convertible debt and acquired Eastern Louisiana oil & gas assets, and Martin Marietta completed a $13.5B acquisition of Lhoist North America. REGENXBIO received an FDA clinical hold on its RGX-121 program, and Hub Group faced a Nasdaq deficiency notice for delayed filings. Kimbell Royalty closed a $221.2M dropdown and raised production guidance, Nutex Health disclosed unauthorized data access, Sable Offshore reported a court-imposed penalty but avoided shutdown, and Cytek Biosciences noted a partial jury verdict with planned appeal."}
LOPE
Grand Canyon Education, Inc.
leadership
negative
materiality 0.70
August 24, 2026, 4:05 PM ET
GCE places CFO Daniel E. Bachus on paid leave amid govt probe into third-party stock trades
- CFO Daniel E. Bachus placed on paid administrative leave effective Aug 21, 2026, tied to government investigation of non-employee's trades in Company stock.
- Company states leave is unrelated to financial statements or accounting policies; Company is not a focus of the investigation.
- Board appointed Lori Browning, SVP & Controller/Chief Accounting Officer, as interim CFO and principal financial officer, effective Aug 21, 2026.
regulatory
negative
materiality 1.00
August 24, 2026, 4:12 PM ET
Northann Corp. gets NYSE American delisting notice; trading suspended, moves to OTC
- NYSE Regulation notified Northann on Aug 21, 2026 it is unsuitable for continued listing under Guide sections 1001, 1002(e), 1003, and 1007.
- Trading of common stock suspended immediately; stock expects to begin OTC Markets quotation under symbol NCLX as soon as Aug 24, 2026.
- Company evaluating appeal to the Listings Qualifications Panel; delisting could reduce liquidity, market price, and ability to raise financing.
M&A
positive
materiality 0.90
August 24, 2026, 8:35 AM ET
Expion Energy raises $9M, acquires Eastern Louisiana oil & gas assets, names new CEO
- $9M 8% convertible debentures due Aug 21, 2029; net proceeds ~$8.2M; warrants for 2,117,219 shares at $4.25 exercise
- Acquires Eastern Louisiana oil & gas target for $3.5M cash (adjusted $3.425M); ~3,000 net acres leasehold, wellbore, 13,000-acre title research
- Exploration agreement: up to $4M commitment, ≥$2.5M for leasing; mandatory lateral well ≥4,000 ft by Feb 15, 2027; ~75% net revenue interest
MLM
MARTIN MARIETTA MATERIALS INC
M&A
positive
materiality 0.90
August 24, 2026, 7:33 AM ET
Martin Marietta closes $13.5B Lhoist North America acquisition; adds director
- Completed LNA acquisition Aug 21, 2026 for ~$7B cash plus 10,953,543 shares valued at $6.5B (total ~$13.5B).
- Board expanded to 11; Philipp Niemann, CEO of Lhoist S.A., appointed director effective Aug 21, 2026.
- LNA Holding lock-up: 50% of shares released at 12 months, 50% at 24 months; standstill caps ownership at 18%.
regulatory
negative
materiality 0.80
August 24, 2026, 5:20 PM ET
FDA clinical hold on REGENXBIO's RGX-121 for MPS II; BLA resubmission not expected near term
- FDA clinical hold on RGX-121 after asymptomatic spine MRI findings in 5 CAMPSIITE study participants.
- REGENXBIO does not expect to resubmit RGX-121 BLA in near term; longer follow-up and data analysis needed.
- All five participants clinically stable/improving; findings deemed nonserious, likely benign by investigators.
regulatory
negative
materiality 0.80
August 24, 2026, 4:35 PM ET
Hub Group gets Nasdaq deficiency notice for delayed Q2 10-Q; faces delisting if filings not cured
- On Aug 20, 2026, received Nasdaq notice of non-compliance with Listing Rule 5250(c)(1) due to delayed Q2 10-Q.
- Must submit updated compliance plan by Aug 27, 2026; any exception capped at Sept 14, 2026 deadline.
- Previously granted 180-day exception for 2025 10-K and Q1 10-Q; restatement of financials ongoing.
KRP
Kimbell Royalty Partners, LP
M&A
positive
materiality 0.80
August 24, 2026, 8:11 AM ET
Kimbell Royalty closes $221.2M dropdown, boosts Q3/Q4 2026 production guidance
- Closed dropdown from Rivercrest/Cupola for ~$221.2M: $74.9M cash + 9.5M OpCo units valued ~$146.3M.
- Acquired assets produce ~2,347 Boe/d (841 bbl oil, 569 bbl NGL, 5,624 Mcf gas) across 3M+ gross acres; effective June 1, 2026.
- Q3 2026 net production guidance raised to 26.5-29.5 Mboe/d (midpoint 10% above prior); Q4 27.7-30.7 Mboe/d (15% above prior).
cyber
negative
materiality 0.80
August 24, 2026, 4:02 PM ET
Nutex Health discloses unauthorized data access and exfiltration from its network
- On Aug 24, 2026, Nutex Health reported unauthorized third-party access and exfiltration of data from its computer network.
- Compromised data may include private/confidential patient, employee, credentialed provider, business and financial information.
- Company engaged independent cybersecurity response team and forensic experts, activated response plan, and notified law enforcement.
litigation
positive
materiality 0.80
August 24, 2026, 6:15 AM ET
Sable Offshore cleared to keep SYPS running; $1.449M penalty, injunctions denied
- Court imposed $1.449M penalty for restarting SYPS without OSFM authorization; denied injunctive shutdown.
- Consent Decree modified: PHMSA substituted for OSFM as regulator; Plains dismissed; no restart violation found.
- California's bid to enjoin DPA Order denied; state filed appeal Aug 20, 2026.
CTKB
Cytek Biosciences, Inc.
litigation
negative
materiality 0.75
August 24, 2026, 6:01 AM ET
Cytek jury verdict: noninfringement on 3 of 4 patent claims, $56.11M damages on 1 claim; appeal planned
- Jury found for Cytek on 3 of 4 asserted claims (noninfringement and invalidity).
- One claim infringed under doctrine of equivalents; damages: $20M lost profits + $36.11M royalties.
- Cytek will pursue post-verdict motions and potential appeal to Federal Circuit.